| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | +0.9% |
| SG&A Expense | $3.7M | -10.2% |
| Operating Income | -$9.8M | +3.2% |
| Pre-tax Income | -$11.6M | +50.2% |
| Net Income | -$11.6M | +50.2% |
| EPS (Basic) | -$8.66 | +22.3% |
| EPS (Diluted) | -$8.66 | +22.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $987K | +470.0% |
| Short-term Investments | $14.8M | +77.4% |
| Current Assets | $16.6M | +76.2% |
| Total Assets | $41.2M | +92.2% |
| Current Liabilities | $5.5M | -17.4% |
| Total Liabilities | $16.4M | +145.3% |
| Stockholders' Equity | $21.8M | +122.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -1.0% |
| Investing Cash Flow | -$8.4M | -38.1% |
| Financing Cash Flow | $18.3M | +45.6% |